STATE COMPLIANCE (A-M)

All states Generic Medical Cannabis Label

ALASKA

Alaska’s cannabis labeling and packaging guidelines include the following:

3 AAC 306.565. Packaging of marijuana products

(a) A marijuana product manufacturing facility shall observe the

potency limits set out in 3 AAC 306.560 in packaging each product for

resale by a retail marijuana store.

(b) A container or packaging for any edible marijuana product

produced by a marijuana product manufacturing facility may not have any

printed images, including cartoon characters, that specifically target

individuals under 21 years of age. In addition, the packaging must

(1) protect the product from contamination and may not

impart any toxic or damaging substance to the product; and

(2) if the marijuana product contains multiple servings, be

designed so that the marijuana product itself has markings or

demarcations clearly delineating each serving of the product; for liquid

marijuana products with multiple servings, the packaging must indicate

the number and size of individual servings.

transfer marijuana products that are not edible marijuana products to

another licensed marijuana product manufacturing facility in wholesale

packages not to exceed five pounds.

(d) Each packaged marijuana product must be identified by a

tracking label generated by the marijuana product manufacturing

facility's marijuana inventory tracking system.

(e)A licensed marijuana product manufacturing facility shall

prepare marijuana products for transfer to another marijuana

establishment by

(1)placing marijuana products within a sealed, tamper-

evident shipping container;

(2) affixing a label that complies with 3 AAC 306.570(d) to

the shipping container; and

(3) generating a transport manifest from the marijuana

product manufacturing facility's marijuana inventory tracking system;

the transport manifest must remain with the marijuana products at all

times while being transported, and a copy must be given to the licensed

marijuana establishment that receives the shipment.

3 AAC 306.570. Labeling of marijuana products

(a) With each production lot of marijuana product sold, a

marijuana product manufacturing facility shall disclose in writing the

name of the licensed marijuana testing facility that performed any

required test and the results of each required test.

(b) A marijuana product may not be labeled as organic.

marijuana store for resale to a consumer, a marijuana product manufacturing facility shall affix a label setting out

(1) the name and license number of the marijuana product

manufacturing facility where the marijuana product was prepared;

(2) the production lot number assigned to the product in the

package;

(3)the net weight of the product in the package,

(A) not including weight of packaging; and

(B)using a standard of measure compatible with the

Marijuana product manufacturing facilities marijuana inventory tracking system; and

(4) each of the following statements:

(A) "Marijuana has intoxicating effects and may be

habit forming and addictive";

(B) "Marijuana impairs concentration, coordination, and

judgment. Do not operate a vehicle or machinery under its influence";

of marijuana";

(D) "For use only by adults twenty-one and older. Keep

out of the reach of children.";

(E) "Marijuana should not be used by women who are

pregnant or breast feeding.".

(d) A marijuana product manufacturing facility transporting a

marijuana product to a retail marijuana store shall affix a label to the

shipping container showing that a licensed marijuana testing facility

has tested each lot of marijuana product in the shipment and giving the

test results, including

(1) a cannabinoid potency profile expressed as a range of

percentages that extends from the lowest percentage to highest

percentage of concentration for each cannabinoid listed from every test

conducted on that production lot from the same marijuana product

manufacturing facility within the last three months;

(2) a statement listing the results of microbial testing

required under 3 AAC 306.645(b)(2);

(3) a statement listing the results of residual solvent

testing required under 3 AAC 306.645(b)(3), if applicable; and

(4) a statement listing any contaminants for which the

product was tested in addition to contaminants for which 3 AAC

306.645(b) requires testing; any additional tested contaminants include

For more information on Alaska's Marijuana program: https://www.commerce.alaska.gov/web/amco/MarijuanaFAQs.aspx

ARKANSAS – Nov 9^th 2016

LABELING

(A) The purpose of this section is to set the minimum standards for the labeling of usable marijuana that is sold to a qualifying patient or designated caregiver by a dispensary or given by a qualifying patient or designated to another qualifying patient or designated caregiver.

(1) Usable marijuana received or transferred by a dispensary, qualifying patient or designated caregiver must meet the labeling requirements in these rules.

(2)(a) A dispensary must return usable marijuana that does not meet labeling requirements in these rules to the individual who transferred it to the dispensary and document to whom the item was returned, what was returned and the date of the return; or (b) Dispose of any usable marijuana that does not meet labeling requirements and that cannot be returned in a manner specified by the Department.

(B) Usable Marijuana Labeling Requirements

(1) Prior to usable marijuana being sold or transferred to a qualifying patient or designated caregiver, the container holding the usable marijuana must have a label that has the following information:

(a) Producer’s business or trade name and cultivation facility or dispensary number;

(b) Business or trade name of cultivation facility or dispensary or cultivation facility or dispensary that packaged or distributed the product, if different from the producer; 8

(d) Date of harvest;

(e) Name of strain;

(f) Net weight in U.S. customary and metric units;

(g) Concentration of THC and CBD;

(h) Activation time expressed in words or through a pictogram;

(i) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(j) Universal symbol;

(k) A warning that states: "For use by qualified patients only. Keep out of reach of children.";

(l) A warning that states: “Marijuana use during pregnancy or breastfeeding poses potential harms.”; and

(m) A warning that states: "This product is not approved by the FDA to treat, cure, or prevent any disease".

(1) Prior to a cannabinoid concentrate or extract being sold or transferred to a qualifying patient or designated caregiver, the container holding the concentrate or extract must have a label that has the following information:

(a) Cultivation facility or dispensary’s business or trade name and cultivation facility or dispensary number;

(b) Business or trade name of cultivation facility or dispensary that packaged or distributed the product, if different from the cultivation facility or dispensary; (c) A unique identification number; (d) Product identity (concentrate or extract);

(e) Date the concentrate or extract was made;

(f) Net weight or volume in U.S. customary and metric units; 9

(g) If applicable, serving size and number of servings per container or amount suggested for use by the qualifying patient at any one time;

(h) Concentration or amount by weight or volume of THC and CBD in each amount suggested for use and in the container;

(i) Activation time, expressed in words or through a pictogram;

(j) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(k) Universal symbol;

(l) A statement that reads:

(i) "This product is not approved by the FDA to treat, cure, or prevent any disease";

(ii) "For use by qualifying patients only. Keep out of reach of children.";

(iii) "DO NOT EAT" in bold, capital letters; and

(iv) “Marijuana use during pregnancy or breastfeeding poses potential harms.”

(D) General Label Requirement, Prohibitions and Exceptions

(1) Principal Display Panel.

(a) Every container that contains usable marijuana for sale or transfer to a qualifying patient or designated caregiver must have a principal display panel.

(b) If a container is placed within packaging for purposes of displaying the marijuana item for sale or transfer to a qualifying patient or designated caregiver, the packaging must have a principal display panel.

(2) A label required by these rules must:

(a) Be placed on the container and on any packaging that is used to display the marijuana item for sale or transfer to a qualified patient or designated caregiver. 10

(b) Comply with the National Institute of Standards and Technology (NIST) Handbook 130 (2017), Uniform Packaging and Labeling Regulation, incorporated by reference.

(i) Statements required by subsections (C)(1)(l)

(ii) and (iv) must be in at least 18 point.

(d) Be in English, though it can also be in other languages; and

(e) Be unobstructed and conspicuous.

(3) Usable marijuana may have one or more labels affixed to the container or packaging.

(4) Usable marijuana that is in a container that because of its size does not have sufficient space for a label that contains all the information required for compliance with these rules:

(a) May have a label on the container that contains usable marijuana and on any packaging that is used to display usable marijuana for sale or transfer to a qualifying patient or designated caregiver that includes at least the following:

(i) Information required on a principal display panel, if applicable for the type of usable marijuana;

(ii) Cultivation facility or dispensary business or trade name and cultivation facility or dispensary number;

(iii) For cultivation facility or dispensaries, a package unique identification number;

(iv) Concentration of THC and CBD; and

(v) Required warnings; and

(b) Must include all other required label information not listed in subsection

(4)(a) on an outer container or package, or on a leaflet that accompanies the usable marijuana.

(5) Usable marijuana in a container that is placed in packaging that is used to display the usable marijuana for sale or transfer to a qualifying patient or designated caregiver must comply with the labeling requirements in these rules, even if the container qualifies for the exception under subsection (4).

(6) The universal symbol: 11

(a) Must be at least 0.48 inches wide by 0.35 inches high.

(b) May only be used by a cultivation facility or dispensary.

(7) A label may not:

(a) Contain any untruthful or misleading statements including, but not limited to, a health claim that is not supported by the totality of publicly available scientific evidence (including evidence from well-designed studies conducted in a manner which is consistent with generally recognized scientific procedures and principles), and for which there is significant scientific agreement, among experts qualified by scientific training and experience to evaluate such claims; or

(b) Be attractive to minors.

(8) Usable marijuana that falls within more than one category must comply with the labeling requirements that apply to both categories, with the exception of the "DO NOT EAT" warning if the product is intended for human consumption.

(9) The THC and CBD amount required to be on a label must be the value calculated by the laboratory that did the testing.

(10) If usable marijuana has more than one test batch number, laboratory, or test analysis date associated with the usable marijuana that is being sold or transferred, each test batch number, laboratory and test analysis date must be included on a label.

(11) If usable marijuana is placed in a package that is being re-used, the old label or labels must be removed and it must have a new label or labels.

(12) Exit packaging must contain a label that reads: "Keep out of the reach of children."to http://www.healthy.arkansas.gov/Documents/The%20Arkansas%20Medical%20Marijuana%20Amendment%20of%202016.pdf

More information

https://static.ark.org/eeuploads/arml/Arkansas_Medical_Marijuana_Amendment_of_2016.pdf

ARIZONA

9-17-317. Product Labeling

A. A dispensary shall ensure that medical marijuana provided by the dispensary to a qualifying patient or a designated caregiver is labeled with:

1. The dispensary’s registry identification number;

2. The amount, strain, and batch number of medical marijuana;

3. The following statement: “ARIZONA DEPARTMENT OF HEALTH SERVICES’ WARNING: Marijuana use can be addictive and can impair an individual’s ability to drive a motor vehicle or operate heavy machinery. Marijuana smoke contains carcinogens and can lead to an increased risk for cancer, tachycardia, hypertension, heart attack, and lung infection. KEEP OUT OF REACH OF CHILDREN”;

4. If not cultivated by the dispensary, whether the medical marijuana was obtained from a qualifying patient, a designated caregiver, or another dispensary;

5. The date of manufacture, harvest, or sale;

6. A list of all chemical additives, including non-organic pesticides, herbicides, and fertilizers, used in the cultivation and production of the medical marijuana; and

7. The registry identification number of the qualifying patient.

B. If a dispensary provides medical marijuana cultivated by the dispensary to another dispensary, the dispensary shall ensure that the medical marijuana is labeled with:

1. The dispensary’s registry identification number;

2. The amount, strain, and batch number of the medical marijuana;

3. The date of harvest or sale; and

4. A list of all chemical additives, including nonorganic pesticides, herbicides, and fertilizers, used in the cultivation of the medical marijuana.

C. If medical marijuana is provided as part of an edible food product, a dispensary shall, in addition to the information in subsection (A), include on the label the total weight of the edible food product

For more information, please refer to the Arizona Department of Health Services for Medical Marijuana.

CALIFORNIA

New Packaging and Labeling requirements - Update 3/2021

Packaging Checklist

https://www.cdph.ca.gov/Programs/CEH/DFDCS/MCSB/CDPH%20Document%20Library/Packaging_Checklist.pdf

Labeling Requirements for Flower and Flower -Only Pre-rolls

https://www.cdph.ca.gov/Programs/CEH/DFDCS/MCSB/CDPH%20Document%20Library/LabelingChecklist-Flower.pdf

Labeling Requirements for Manufactured Cannabis Products.

https://www.cdph.ca.gov/Programs/CEH/DFDCS/MCSB/CDPH%20Document%20Library/LabelingChecklist-Products.pdf

CHAPTER 12. Packaging and Labeling [26120- 26120.]

( Chapter 12 added November 8, 2016, by initiative Proposition 64, Sec. 6.1. )

26120.

(a) Prior to delivery or sale at a retailer, marijuana and marijuana products shall be labeled and placed in a resealable, child resistant package.

(b) Packages and labels shall not be made to be attractive to children.

(c) All marijuana and marijuana product labels and inserts shall include the following information prominently displayed in a clear and legible fashion in accordance with the requirements, including font size, prescribed by the bureau or the State Department of Public Health:

(1) Manufacture date and source.

(2) The following statements, in bold print:

(A) For marijuana: “GOVERNMENT WARNING: THIS PACKAGE CONTAINS MARIJUANA, A SCHEDULE I CONTROLLED SUBSTANCE. KEEP OUT OF REACH OF CHILDREN AND ANIMALS. MARIJUANA MAY ONLY BE POSSESSED OR CONSUMED BY PERSONS 21 YEARS OF AGE OR OLDER UNLESS THE PERSON IS A QUALIFIED PATIENT. MARIJUANA USE WHILE PREGNANT OR BREASTFEEDING MAY BE HARMFUL. CONSUMPTION OF MARIJUANA IMPAIRS YOUR ABILITY TO DRIVE AND OPERATE MACHINERY. PLEASE USE EXTREME CAUTION.”

(B) For marijuana products: “GOVERNMENT WARNING: THIS PRODUCT CONTAINS MARIJUANA, A SCHEDULE I CONTROLLED SUBSTANCE. KEEP OUT OF REACH OF CHILDREN AND ANIMALS. MARIJUANA PRODUCTS MAY ONLY BE POSSESSED OR CONSUMED BY PERSONS 21 YEARS OF AGE OR OLDER UNLESS THE PERSON IS A QUALIFIED PATIENT. THE INTOXICATING EFFECTS OF MARIJUANA PRODUCTS MAY BE DELAYED UP TO TWO HOURS. MARIJUANA USE WHILE PREGNANT OR BREASTFEEDING MAY BE HARMFUL. CONSUMPTION OF MARIJUANA PRODUCTS IMPAIRS YOUR ABILITY TO DRIVE AND OPERATE MACHINERY. PLEASE USE EXTREME CAUTION.”

(3) For packages containing only dried flower, the net weight of marijuana in the package.

(4) Identification of the source and date of cultivation, the type of marijuana or marijuana product and the date of manufacturing and packaging.

(5) The appellation of origin, if any.

(6) List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoid content, the THC and other cannabinoid amount in milligrams per serving, servings per package, and the THC and other cannabinoid amount in milligrams for the package total, and the potency of the marijuana or marijuana product by reference to the amount of tetrahydrocannabinol and cannabidiol in each serving.

(7) For marijuana products, a list of all ingredients and disclosure of nutritional information in the same manner as the federal nutritional labeling requirements in Section 101.9 of Title 21 of the Code of Federal Regulations.

(8) A list of any solvents, nonorganic pesticides, herbicides, and fertilizers that were used in the cultivation, production, and manufacture of such marijuana or marijuana product.

(9) A warning if nuts or other known allergens are used.

(10) Information associated with the unique identifier issued by the Department of Food and Agriculture.

(11) Any other requirement set by the bureau or the State Department of Public Health.

(d) Only generic food names may be used to describe the ingredients in edible marijuana products.

(e) In the event the bureau determines that marijuana is no longer a schedule I controlled substance under federal law, the label prescribed in subdivision (c) shall no longer require a statement that marijuana is a schedule I controlled substance.

(Added November 8, 2016, by initiative Proposition 64, Sec. 6.1.)

For more information on California’s regulations, see the Guidelines for the Security and Non-Diversion of Marijuana Grown for Medical Use, and the SF Medical Cannabis Dispensary Regulations.

COLORADO

Colorado’s cannabis labeling and packaging guidelines state that before sale to a consumer, a retail marijuana store must place any cannabis products in a container that adheres to the following restrictions:

Is child-resistant or is placed into an “exit package” that is child-resistant;
Is opaque;
Is closable if not intended for single use;
Is properly labeled pursuant to the Colorado Retail Marijuana Code
- The packaging may not be designed to appeal to children
- The labeling makes no false or misleading statements regarding health or physical benefits to the consumer
- Labeling text is no smaller than 1/16 of an inch
- Labeling text must be clearly written or printed and in the English language
- Labeling text must be unobstructed and conspicuous
Includes Colorado’s Universal THC Symbol

Additionally, containers for edible marijuana products must be labeled with all ingredients.

For more information, please refer to both the Colorado Retail Marijuana Code, which includes additional guidelines for shipping containers, contaminant and potency testing, and more, as well as Colorado’s Packaging & Labeling Requirements For Retail Marijuana for Consumer Protection and Child Safety.

LABELING RULES EFFECTIVE OCTOBER 1, 2017
Edibles in the Shape of Human, Animal or Fruit
The Medical Marijuana Code (“Medical Code”) and Retail Marijuana Code (“Retail Code”) mandate that the State Licensing Authority promulgate rules prohibiting the production and sale of marijuana products “that are in the distinct shape of a human, animal, or fruit” and that such rules shall take effect on October 1, 2017.1 Consistent with this requirement, the State Licensing Authority promulgated rules expressly prohibiting the production, sale or donation of edible medical marijuana‐infused products and edible retail marijuana products (collectively referred to herein as “Edible Products”) in the distinct shape of a human, animal or fruit, or a shape that bears the likeness or contains the characteristics of a realistic or fictional human, animal, or fruit, including
artistic, caricature, or cartoon renderings.

2  Medical Marijuana Centers and Retail Marijuana Stores: Beginning October 1, 2017,
Medical Marijuana Centers and Retail Marijuana Stores shall not purchase, take possession of, sell, or donate non‐compliant Edible Products.
 Medical Marijuana‐Infused Products Manufacturers and Retail Marijuana Products
Manufacturing Facilities: Beginning October 1, 2017, Medical Marijuana‐Infused Products
Manufacturers and Retail Marijuana Product Manufacturing Facilities shall neither produce
non‐compliant Edible Products nor sell, transfer or donate non‐compliant Edible Products to another Medical Marijuana Business or Retail Marijuana Establishment.

Any Medical Marijuana Business or Retail Marijuana Establishment in possession of non‐compliant
Edible Products on or after October 1, 2017 shall follow waste disposal procedures pursuant to Rules M and R 307, 1 CCR 212‐1 and 1 CCR 212‐2.

Child Resistant Certificate(s). A Licensee shall maintain a copy of the certificate showing that each Child-Resistant Container into which the Licensee places Medical Marijuana, Medical Marijuana Concentrate, or Medical Marijuana-Infused Product is Child-Resistant and complies with the requirements of 16 C.F.R. 1700.15 (1995) and 16 C.F.R. 1700.20 (1995) in accordance with the requirements of Rule M 901(A).

CONNECTICUT

Connecticut’s cannabis labeling and packaging guidelines come from Sec. 21a-408-56 of its regulations:

A producer shall individually package, label, and seal marijuana products in unit sizes such that no single unit contains more than a one-month supply of marijuana.
A producer shall place any product containing marijuana in a child-resistant and light-resistant package.
A producer shall label each marijuana product prior to sale to a dispensary and shall securely affix to the package a label that states in legible English:
- (1) The name and address of the producer;
- (2) The brand name of the marijuana product that was registered with the department;
- (3) A unique serial number that will match the product with a producer batch and lot number so as to facilitate any warnings or recalls the department or producer deem appropriate;
- (4) The date of final testing and packaging;
- (5) The expiration date;
- (6) The quantity of marijuana contained therein;
- (7) A terpenes profile and a list of all active ingredients, including:
  - (A) tetrahydrocannabinol (THC);
  - (B) tetrahydrocannabinol acid (THCA);
  - (C) cannabidiol (CBD); (D) cannabidiolic acid (CBDA); and
  - (E) any other active ingredient that constitute at least 1% of the marijuana batch used in the product.
- (8) A pass or fail rating based on the laboratory’s microbiological, mycotoxins, heavy metals, and chemical residue analysis.

For more information, please refer to the State of Connecticut Regulation of the Department of Consumer Protection Concerning Palliative Use of Marijuana.

DELAWARE

Delaware’s cannabis labeling and packaging guidelines include a description of the packaging of the useable marijuana that the compassion center shall be utilizing which shall, a minimum, include:

The name of the strain, batch, and quantity;
The statement “this product is for medical use only, not for resale;”
Details indicating
- (1) the medical marijuana is free of contaminants, and
- (2) the levels of active ingredients in the product.

For more information, please refer to 4470 State of Delaware Medical Marijuana Code.

DISTRICT OF COLUMBIA

Washington D.C.’s cannabis labeling and packaging guidelines state that no medical marijuana shall be dispensed or distributed to a qualifying patient or caregiver unless the container in which it is distributed bears a legible label, firmly affixed, stating the following information:

(a) The name of the cultivation center where the medical marijuana was produced;
(b) The name of the dispensary where the medical marijuana was dispensed;
(c) The quantity of medical marijuana contained within;
(d) The cannabinoid profile of the medical marijuana contained within, including the THC level;
(e) Any other ingredient or ingredients besides medical marijuana contained within;
(f) The name of the recommending physician;
(g) The dispensing date that the medical marijuana was transferred to the qualified patient or caregiver;
(h) The qualifying patient’s name and registration card number; and
(i) A statement that the product is for medical use and not for resale or transfer to another person.

For more information, please refer to the D.C. Municipal Regulations and D.C. Register.

FLORIDA

Package the low-THC cannabis or medical cannabis in compliance with the United States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss. 1471 et seq.
Package the low-THC cannabis or medical cannabis in a receptacle that has a firmly affixed and legible label stating the following information:
A statement that the low-THC cannabis or medical cannabis meets the requirements of subparagraph 2.;
The name of the dispensing organization from which the medical cannabis or low-THC cannabis originates; and
The batch number and harvest number from which the medical cannabis or low-THC cannabis originates.

For Further Information contact: http://www.leg.state.fl.us/statutes/index.cfm?mode=View%20Statutes&SubMenu=1&App_mode=Display_Statute&Search_String=381.986&URL=0300-0399/0381/Sections/0381.986.html

HAWAII

Hawaii’s cannabis labeling and packaging guidelines come from Hawaii House Bill 321:

(a) The department shall establish standards regarding the advertising and packaging of medical marijuana products; provided that the standards, at a minimum, shall require the use of packaging that:
- (1) Is child-resistant and opaque so that the product cannot be seen from outside the packaging;
- (2) Is clearly labeled with the phrase “For medical use only”; and
- (3) Contains information about the contents and potency of the product.
(b) Any lozenge, capsule, or pill containing medical marijuana or its principal psychoactive constituent tetrahydrocannabinol shall be packaged so that one dose, serving, or single wrapped item contains no more than ten milligrams of tetrahydrocannabinol.

For more information, please refer to House Bill 321 Relating to Medical Marijuana.

ILLINOIS

Illinois’ cannabis labeling and packaging guidelines include the following:

Each cannabis product produced for sale shall be registered with the Department on forms provided by the Department.
a) Each product registration shall include a label and the required registration fee (Section 1000.140). The registration fee is for the name of the product offered for sale, and one fee shall be sufficient for all package sizes.
b) All harvested cannabis intended for distribution to a dispensing organization must be packaged in a sealed and labeled medical cannabis container.
c) Packaging of any product containing cannabis shall be child-resistant and light-resistant consistent with current standards, including the Consumer Product Safety Commission standards referenced by the Poison Prevention Act.
d) Each cannabis product shall be labeled by the cultivation center prior to sale to a dispensary, and each label shall be securely affixed to the package and shall state in legible English:
- 1) The name and P.O. Box of the registered cultivation center where the item was manufactured;
- 2) The common or usual name of the item and the registered name of the cannabis product that was registered with the Department pursuant to subsection (a);
- 3) A unique serial number that will match the product with a producer batch and lot number to facilitate any warnings or recalls the Department or producer deems appropriate;
- 4) The date of final testing and packaging, if sampled, and the identification of the independent testing laboratory;
- 5) The date of manufacture and “use by” date;
- 6) The quantity (in ounces or grams) of cannabis contained in the product;
- 7) A pass/fail rating based on the laboratory’s microbiological, mycotoxins, and pesticide and solvent residue analyses, if sampled;
- 8) Content List
  - A) A list of the following, including the minimum and maximum percentage content by weight for subsections (d)(8)(A)(i) through (iv):
    - i) delta-9-tetrahydrocannabinol (THC);
    - ii) tetrahydrocannabinolic acid (THCA);
    - iii) cannabidiol (CBD);
    - iv) cannabidiolic acid (CBDA); and
    - v) any other ingredients besides cannabis.
  - B) The acceptable tolerances for the minimum percentage printed on the label for any of subsections (d)(8)(A)(i) through (iv) shall not be below 85% or above 115% of the labeled amount;
- 9) A statement that the product is for medical use and not for resale or transfer to another person.

For more information, please refer to the General Provisions for the Compassionate Use of Medical Cannabis Pilot Act.

Louisiana

Report No. 1 of 3 for Regulatory Project 2016-6 — Marijuana Pharmacy

§2443. Marijuana products

D. Packaging and Labeling Requirements.

1. Packaging.

a. The producer shall ensure every product intended for dispensing to a patient is placed within a child-resistant, light-resistant, tamper-evident container prior to sale or transport to the pharmacy.

i. A package shall be deemed child-resistant if it satisfies the standard for ‘special packaging’ as set forth in the United States Consumer Product Safety Commission’s Poison Prevention Packaging as found in 16 CFR 1700.1(b)(4) or its successor.

ii. A package shall be deemed light-resistant if it satisfies the standard set forth in Chapter 671 – Containers: Performance Testing of the United States Pharmacopeia (USP).

iii. A package shall be deemed tamper-evident if it clearly indicates prior access to the container.

b. Any product containing pharmaceutical grade marijuana or its principal psychoactive constituent tetrahydrocannabinol (THC) shall be packaged so that one dose contains no more than 10 milligrams of THC.

c. If it is not intended for the entire product to be used at a single time, the packaging must be resealable in a manner that maintains its child-resistant property for multiple openings. Single doses may be placed in a package with other single doses; however, the total amount of active THC contained within the larger packaging shall not exceed 100 milligrams.

d. No single container shall contain more than a one month supply of marijuana.

e. Packaging selected by the producer shall be subject to the following restrictions.

i. Shall not specifically target individuals under the age of 21 years;

ii. Shall not bear any resemblance to a trademarked, characteristic or product-specialized packaging of any commercially available candy, snack, baked good or beverage;

iii. Shall not use the words “candy” or “candies”; iv. Shall not use a cartoon, color scheme, image, graphic or feature that might make the package attractive to children; and v. Shall not use a seal, flag, crest, coat of arms or other insignia that could reasonably lead any person to believe the product has been endorsed, manufactured by, or used by any state, parish, municipality, or any agent thereof.

2. Labeling.

a. Each product shall be labeled by the producer prior to its sale to the marijuana pharmacy. Each label shall be securely affixed to the package and shall include, at a minimum:

i. The batch or lot number assigned by the producer to the marijuana plant(s) from which the marijuana used in the product was harvested;

ii. A complete list of solvents, chemicals, and pesticides used in the creation of any marijuana concentrate;

iii. A complete list of all ingredients used to manufacture the product, which may include a list of any potential allergens contained within, or used in the manufacture of, a product;

iv. The potency of the THC and CBD in the product, expressed in milligrams for each cannabinoids;

v. The net weight, using a standard of measure compatible with the LMMTS, of the product prior to its placement in the shipping container;

vi. A product expiration date, upon which the product will no longer be fit for use. Once a label with an expiration date has been affixed to a product, the producer shall not alter that date or affix a new label with a later date; and

vii. A statement the product has been tested for contaminants, that there were no adverse findings, and the date of such testing.

b. The labeling text on any marijuana product shall not make any false or misleading statements regarding health or physical benefits to the consumer. Further, each label shall include all of the following statements:

i. “Contains Marijuana. For Medical Use Only. KEEP OUT OF THE REACH OF CHILDREN.”

ii. “Marijuana can impair concentration, coordination, and judgment. Do not operate a vehicle or machinery under the influence of this drug.”

iii. “There may be additional health risks associated with the consumption of this product for women who are pregnant, breastfeeding, or planning to become pregnant.”

iv. A statement that it is illegal for any person to possess or consume the contents of the package other than the patient for whom it was recommended.

c. The labeling text required by this Section shall be no smaller than 1/16 of an inch, shall be printed in English, and must be unobstructed and conspicuous.

http://www.pharmacy.la.gov/assets/docs/Cmtes/RegRev/RegProj2016-6_OversightCmteRpt1.pdf

MAINE

Maine’s cannabis labels on prepared marijuana and goods containing marijuana that are sold by dispensaries and caregivers are used as evidence of compliance with the law that limits possession and dispensing to 2.5 ounces of prepared marijuana per qualifying patient. The packaging and labeling of prepared marijuana and marijuana products for sale by registered dispensaries and caregivers must comply with applicable State labeling laws. See 22 M.R.S.A. §2157.

For more information, please refer to the Rules Governing the Maine Medical Use of Marijuana Program.

MARYLAND

Maryland’s cannabis labeling and packaging guidelines include the following:

Packaging of Medical Cannabis Finished Product

All items shall be individually packaged at the original point of processing.
Packaging Requirements. A package of medical cannabis finished product shall:

(1) Be plain;

(2) Be opaque;

(3) Be tamper-evident, and if applicable or appropriate, child-resistant;

(4) Bear a finished-product lot number and an expiration date;

(5) Bear a clear warning that:

(a) The contents may be lawfully consumed only by a qualifying patient named on an attached label;

(b) It is a illegal for any person to possess or consume the contents of the package other than the qualifying patient; and

(c) It is a illegal to transfer the package or contents to any person other than a transfer by a caregiver to a qualifying patient;

(6) Bear a clear warning to keep the package and its contents away from children other than a qualifying patient;

(7) Bear the Maryland Poison Control Center emergency telephone number;

(8) Bear the name of the licensee that packaged the medical cannabis finished product and the telephone number of the licensee for reporting an adverse patient event;

(9) Bear any allergen warning required by law;

(10) Bear a listing of the non-medical cannabis ingredients;

(11) Bear an itemization, including weight, of all cannabinoid and terpene ingredients specified for the product, and concentrates of any cannabinoid of less than one percent shall be printed with a leading zero before the decimal point; and

(12) Leave space for a licensed dispensary to attach a personalized label for the qualifying patient.

Packaging Prohibitions. A package of medical cannabis finished product may not bear any:

(1) Resemblance to the trademarked, characteristic or product-specialized packaging of any commercially available candy, snack, baked good or beverage;

(2) Statement, artwork or design that could reasonably mislead any person to believe that the package contains anything other a medical cannabis finished product;

(3) Seal, flag, crest, coat of arms, or other insignia that could reasonably mislead any person to believe that the product has been endorsed, manufactured, or used by any State, county or municipality or any agency thereof; and

(4) Cartoon, color scheme, image, graphic or feature that might make the package attractive to children.

Label for Distribution to a Qualifying Patient

A licensee shall print a label for a package of medical cannabis for a qualifying patient in English in letters no less than one-sixteenth of an inch high. If requested by a qualifying patient or caregiver, the licensee may also print a label in another language.
A licensee may not distribute a package of medical cannabis without a label securely attached.
A licensee shall state on a label of a package of medical cannabis:

(1) The name of the qualifying patient;

(2) The name of the certifying physician;

(3) The name of the licensee where the product was dispensed;

(4) The date that the medical cannabis was dispensed;

(5) The name of the product;

(6) The strength of applicable cannabinoid and terpene compounds:

(a) Displayed in units appropriate to the dosage form; and

(b) Concentrations of any cannabinoid of less than one percent shall be printed with a leading zero before the decimal point;

(7) The quantity of medical cannabis dispensed, displayed in units appropriate to the dosage form;

(8) Any directions for use of the product; and

(9) The instructions for proper storage or handling of the product.

Any other information required by the dispensary at its discretion may be provided in a patient insert.
The label may not:

(1) Contain any false or misleading statement or design; or

(2) Include any statement, image or design that may not be included on the package.

For more information, please refer to the Subtitle 62 of the Maryland Department of Health & Mental Hygiene.

MASSACHUSETTS

Massachusetts’ cannabis labeling and packaging guidelines include the following:

(E) Packaging and Labeling
- (1) Marijuana shall be packaged in plain, opaque, tamper-proof, and child-proof containers without depictions of the product, cartoons, or images other than the RMD’s logo. Edible MIPs shall not bear a reasonable resemblance to any product available for consumption as a commercially available candy.
- (2) Labeling of Marijuana (Excluding MIPs). The RMD shall place a legible, firmly affixed label on which the wording is no less than 1/16 inch in size on each package of marijuana that it prepares for dispensing, containing at a minimum the following information:
  - (a) The registered qualifying patient’s name;
  - (b) The name and registration number of the RMD that produced the marijuana, together with the RMD’s telephone number and mailing address, and website information, if any;
  - (c) The quantity of usable marijuana contained within the package;
  - (d) The date that the RMD packaged the contents;
  - (e) A batch number, sequential serial number, and bar code when used, to identify the batch associated with manufacturing and processing;
  - (f) The cannabinoid profile of the marijuana contained within the package, including THC level;
  - (g) A statement that the product has been tested for contaminants, that there were no adverse findings, and the date of testing in accordance with 105 CMR 725.105(C)(2); and
  - (h) This statement, including capitalization: “This product has not been analyzed or approved by the FDA. There is limited information on the side effects of using this product, and there may be associated health risks. Do not drive or operate machinery when under the influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN.”
- (3) Labeling of MIPs. The RMD shall place a legible, firmly affixed label on which the wording is no less than 1/16 inch in size on each MIP that it prepares for dispensing, containing at a minimum the following information:
  - (a) The registered qualifying patient’s name;
  - (b) The name and registration number of the RMD that produced the MIP, together with the RMD’s telephone number and mailing address, and website information, if any;
  - (c) The name of the product;
  - (d) The quantity of usable marijuana contained within the product as measured in ounces;
  - (e) A list of ingredients, including the cannabinoid profile of the marijuana contained within the product, including the THC level;
  - (f) The date of product creation and the recommended “use by” or expiration date;
  - (g) A batch number, sequential serial number, and bar code when used, to identify the batch associated with manufacturing and processing;
  - (h) Directions for use of the product if relevant;
  - (i) A statement that the product has been tested for contaminants, that there were no adverse findings, and the date of testing in accordance with 105 CMR 725.105(C)(2);
  - (j) A warning if nuts or other known allergens are contained in the product; and
  - (k) This statement, including capitalization: “This product has not been analyzed or approved by the FDA. There is limited information on the side effects of using this product, and there may be associated health risks. Do not drive or operate machinery when under the influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN.”

For more information, please refer to the Implementation of an Act for the Humanitarian Medical Use of Marijuana.

MICHIGAN

Michigan currently has no cannabis labeling and packaging requirements.

For more information, please refer to the Michigan Medical Marihuana Program.

MINNESOTA

Minnesota’s cannabis labeling and packaging guidelines include the following:

0850 PACKAGING AND LABELING. Subpart 1. Medical cannabis packaging. The medical cannabis manufacturer must package all medical cannabis intended for distribution according to the following standards:
In addition to the requirements in Minnesota Statutes, section 152.29, subdivision 3, paragraph (c), clause (5), medical cannabis containers must be:
- (1) plain;
- (2) designed to maximize the shelf life of contained medical cannabis;
- (3) tamper-evident; and
- (4) child-resistant.
Medical cannabis packaging must not bear a reasonable resemblance to any commercially available product.
Medical cannabis packaging must be packaged to minimize its appeal to children and must not depict images other than the medical cannabis manufacturer’s business name logo. Subp. 2. Medical cannabis trade names. The medical cannabis manufacturer’s medical cannabis trade names must comply with the following standards and are subject to approval by the commissioner:
- names that are limited to those that clearly reflect the product’s medical cannabis nature;
- any name that is identical to, or confusingly similar to, the name of an existing non-cannabis product is prohibited;
- any name that is identical to, or confusingly similar to, the name of an unlawful product or substance is prohibited; and
- any name that contains language that suggests using medical cannabis for recreational purposes or for a condition other than a qualifying medical condition is prohibited. Subp. 3. Labeling. A. A medical cannabis manufacturer must ensure that all medical cannabis that is distributed is labeled with the following information:
  - (1) the patient’s registry identification number, name, and date of birth;
  - (2) the name and date of birth of the designated registered caregiver, if applicable;
  - (3) the name of the patient’s parent or legal guardian, if listed on the registry verification, if applicable;
  - (4) the patient’s address;
  - (5) the name and address of the medical cannabis manufacturer where the medical cannabis was manufactured;
  - (6) the medical cannabis’s chemical composition;
  - (7) the recommended dosage;
  - (8) directions for use of the product;
  - (9) all ingredients of the product shown with common or usual names, including any colors, artificial flavors, and preservatives, listed in descending order by predominance of weight;
  - (10) the date of manufacture and batch number;
  - (11) a notice with the statement, including capitalization: “This product has not been analyzed or approved by the United States Food and Drug Administration. There is limited information on the side effects of using this product, and there may be associated health risks. Do not drive or operate heavy machinery when under the influence of this product. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.”; and
  - (12) a notice with the statement: “This medical cannabis is for therapeutic use only. Diversion of this product is unlawful and may result in the revocation of the patient’s registration.”
- Labeling text must not include any false or misleading statements regarding health or physical benefits to the patient.
- A package may contain multiple labels if the information required by this part is not obstructed.

For more information, please refer to the Minnesota Revisor of Statutes on Packaging and Labeling.

MONTANA - NOV 2016

Consumer Safety

Strict Packaging Requirements ◦ Limited servings and concentration per package

Maximum 10 mg THC per serving, 100 mg per package
Servings individually wrapped
Homogenized to ensure uniform THC concentration ◦ Packaging
Child-resistant (including individual servings)
No easy-open tab, tamperproof
Liquids require measuring device ◦ Upon request
Third party lab that tests lot and results
All pesticides, herbicides, fungicides found in product